Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.